Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Adynxx Inc
ADYX

Buy Adynxx Inc (ADYX) Stock

ADYX
See ADYX stock price and Buy/Sell Adynxx Inc with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
ADYX

Adynxx Inc (ADYX)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Adynxx Inc (ADYX)

Adynxx, Inc. is a clinical stage biopharmaceutical company. It engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in October, 2007 and is headquartered in San Francisco, CA.
Market Cap
$600
1 Year High
$0.38
Volume
1 Year Low
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch ADYX stock

Adynxx Inc stock rating

What analysts recommend for ADYX stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
3

Adynxx Inc price target

What analysts think ADYX will be worth
Low $0
High $2.80
Current $0
Target $2.80

Events

List of events that could affect ADYX stock.
14Nov

Earnings data Q3 2019

19May

Earnings data Q1 2020

Adynxx Inc earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.11
-0.22
-0.33
Q3 2019

Expected EPS
Q3 2019
-$0.33
Actual EPS
Q3 2019
-$0.33

Buy Adynxx Inc (ADYX) Stock

ADYX
See ADYX stock price and Buy/Sell Adynxx Inc with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch ADYX stock
  • bullishamc avatar
  • ericsretirement22 avatar
  • ANIMAL1175 avatar
  • kdeeinc avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.